Ultragenyx Pharmaceutical
RARE
#3663
Rank
NZ$6.07 B
Marketcap
NZ$62.97
Share price
-0.44%
Change (1 day)
-21.75%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: NZ$6.07 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of NZ$6.07 Billion. This makes Ultragenyx Pharmaceutical the world's 3663th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$6.07 B-14.54%
2024NZ$7.10 B14.5%
2023NZ$6.20 B21.37%
2022NZ$5.11 B-39.04%
2021NZ$8.39 B-33.88%
2020NZ$12.69 B246.03%
2019NZ$3.66 B11.26%
2018NZ$3.29 B18.54%
2017NZ$2.78 B-32.94%
2016NZ$4.14 B-34.92%
2015NZ$6.37 B256.34%
2014NZ$1.78 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

NZ$6.07 Billion
by Nasdaq info icon info icon
NZ$6.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$17.75 B 192.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$5.28 B-12.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.53 B-74.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$0.88 B-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA